Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

QL03-70

Phase II Trial of Olanzapine (Zyprexa) and Palonosetron (Aloxi) for the Prevention of Chemotherapy Induced Nausea and Vomiting

Abstracts/Posters/Presentations:

  • R. M. Navari, L. H. Einhorn, P. J. Loehrer, S. D. Passik, J. Vinson, J. McClean, N. Chowhan, N. Hanna, C. Calley, M. Yu. A Phase II Trial of Olanzapine (Zyprexa) and Palonosetron (Aloxi) for the Prevention of Chemotherapy Induced Nausea and Vomiting: Hoosier Oncology Group QL03-70. Accepted to the ASCO annual meeting June 2-6, 2006, Atlanta, Georgia
  • R. M. Navari, L. H. Einhorn, P. J. Loehrer, S. D. Passik, J. Vinson, J. McClean, N. Chowhan, N. Hanna, C. Calley, M. Yu. A phase II trial of olanzapine and palonosetron for the prevention of chemotherapy induced nausea and vomiting (CINV) QL03-70. Accepted as a poster presentation at the ASCO Annual Meeting, June 2-6, 2006, Atlanta, GA. J Clin Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 8608

Manuscripts/Articles:

  • Rudolph M. Navari, Lawrence H. Einhorn, , Patrick J. Loehrer Sr., Steven D. Passik, Jake Vinson, John McClean, Naveed Chowhan, Nasser Hanna, Cynthia Johnson:A Phase II Trial of Olanzapine, Dexamethasone and Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Hoosier Oncology Group Study QL03-70. Support Care Cancer. 2007 Mar 21: 17375339 (P,S,E,B,D)